Bayer says oral contraceptive YAZ receives approval in the Netherlands - drug also clears acne
Bayer AG said its low-dose oral contraceptive YAZ received regulatory approval in the Netherlands, both for preventing unwanted pregnancies and treating acne. This regulatory nod -- the first in Europe -- will serve as a reference in the EU mutual recognition procedure that Bayer plans to launch in order to gain Europe-wide marketing approval.
YAZ has been on the US market since April 2006 and posts the highest growth rate among brand-name contraceptives.
No comments:
Post a Comment